◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

KOSE Holdings Corporation (4922) EPS 2022–2025

Name: KOSE Holdings Corporation (4922) eps history 2022-2025
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-11

KOSE Holdings Corporation annual earnings per share (EPS) for fiscal 2025 was JPY 264.84, an increase of 101.2% from JPY 131.62 in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

4922 Annual EPS

EPS (annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Diluted EPS	JPY 265M	JPY 132M	JPY 204M	JPY 329M

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4922 Quarterly EPS

EPS (quarterly)	2026-03-31	2025-03-31
Diluted EPS	JPY 7M	JPY 93M

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EPS at Comparable Companies

4527 EPS — Rohto Pharmaceutical Co.,Ltd.
4912 EPS — Lion Corporation
4967 EPS — Kobayashi Pharmaceutical Co., Ltd.
8283 EPS — Paltac Corporation
4927 EPS — Pola Orbis Holdings Inc.
7956 EPS — Pigeon Corporation

More 4922 metrics: Revenue · Gross Profit · Operating Income · Net Income · Free Cash Flow

All 4922 financial statements → Interactive 4922 charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.